Vous n'êtes pas connecté
Record-Breaking Revenue of HK$553.0M and Net Profit of HK$82.8M First-ever Dividend was HK$0.277 Cents Per Share Strengthening Presence in Osteoporosis, Ophthalmology, and Aesthetic Medical Markets HONG KONG SAR - EQS Newswire - 27 March 2025 - A fully integrated biopharmaceutical company - ...